Tavist and Angina pectoris aggravated - a phase IV clinical study of FDA data


Angina pectoris aggravated is found among people who take Tavist, especially for people who are female, 60+ old, have been taking the drug for 10+ years.

The phase IV clinical study analyzes which people take Tavist and have Angina pectoris aggravated. It is created by eHealthMe based on reports of 2,140 people who have side effects when taking Tavist from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

2,140 people reported to have side effects when taking Tavist.
Among them, 19 people (0.89%) have Angina pectoris aggravated.

What is Tavist?

Tavist has active ingredients of clemastine fumarate. eHealthMe is studying from 2,148 Tavist users for its effectiveness, alternative drugs and more.

What is Angina pectoris aggravated?

Angina pectoris aggravated (aggravated-chest pain due to ischemia of the heart muscle) is found to be associated with 1,585 drugs and 475 conditions by eHealthMe.

Number of Tavist and Angina pectoris aggravated reports submitted per year:

Could Tavist cause Angina pectoris aggravated?

Time on Tavist when people have Angina pectoris aggravated *:

  • < 1 month: 40 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 60 %

Gender of people who have Angina pectoris aggravated when taking Tavist *:

  • female: 77.78 %
  • male: 22.22 %

Age of people who have Angina pectoris aggravated when taking Tavist *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 23.53 %
  • 50-59: 35.29 %
  • 60+: 41.18 %

Common drugs people take besides Tavist *:

  1. Dimetapp: 12 people, 63.16%
  2. Tylenol: 6 people, 31.58%
  3. Nifedipine: 5 people, 26.32%
  4. Advil Cold And Sinus: 4 people, 21.05%
  5. Contac: 4 people, 21.05%
  6. Hydrochlorothiazide: 4 people, 21.05%
  7. Evista: 3 people, 15.79%
  8. Ditropan: 3 people, 15.79%
  9. Lasix: 3 people, 15.79%
  10. Premarin: 3 people, 15.79%

Common side effects people have besides Angina pectoris aggravated *:

  1. Joint Pain: 5 people, 26.32%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 21.05%
  3. High Blood Pressure: 4 people, 21.05%
  4. Cerebral Infarction (less blood supply to brain resulting tissue damage): 4 people, 21.05%
  5. Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 4 people, 21.05%
  6. Heart Attack: 3 people, 15.79%
  7. Cerebral Artery Occlusion (blockage of blood vessel of brain by fat or clot): 3 people, 15.79%
  8. Chest Pain: 3 people, 15.79%
  9. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 15.79%
  10. Cardiac Failure Congestive: 2 people, 10.53%

Common conditions people have *:

  1. Sinus Congestion (blockage of sinus): 2 people, 10.53%
  2. Nasopharyngitis (inflammation of the nasopharynx): 2 people, 10.53%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Tavist and have Angina pectoris aggravated?

Check whether Angina pectoris aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Angina pectoris aggravated and when was it recovered:

Expand to all the drugs that have ingredients of clemastine fumarate:

Alternative drugs to, pros and cons of Tavist:

Common Tavist side effects:

Browse all side effects of Tavist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Angina pectoris aggravated treatments and more:

COVID vaccines that are related to Angina pectoris aggravated:

Common drugs associated with Angina pectoris aggravated:

All the drugs that are associated with Angina pectoris aggravated:

Common conditions associated with Angina pectoris aggravated:

All the conditions that are associated with Angina pectoris aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on clemastine fumarate (the active ingredients of Tavist) and Tavist (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: